Clinical Trials Directory

Trials / Completed

CompletedNCT04724551

The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula

The Neutrophil-to-Lymphocyte Ratio at Post-operative Day 3: a Simple Tool to Exclude Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy

Status
Completed
Phase
Study type
Observational
Enrollment
648 (actual)
Sponsor
Institut Paoli-Calmettes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is still no consensus on whether drain fluid amylase (DFA) level, C-reactive protein (CRP) level, or complex scores predict clinically relevant postoperative pancreatic fistula (CR-POPF). The aim of this study is to determine the accuracy of simple biochemical parameters (leucocytes, neutrophils, lymphocytes, Neutrophil to Lymphocytes Ratio (NLR), at postoperative days 1 and 3) to exclude the diagnosis of CR-POPF.

Detailed description

From January 1, 2012 to December 31, 2020, consecutive patients underwent PD performed at Institut Paoli-Calmettes for various pathologies. Data were entered prospectively into a clinical database (NCT02871336). The cohort was split into 3 groups: * a training cohort ; * an internal validation cohort (Paoli Calmettes institute); * an external validation cohort (Rennes Pontchaillou Hospital).

Conditions

Interventions

TypeNameDescription
PROCEDUREpancreatoduodenectomy (PD)A pancreaticogastrostomy or -jejunostomy duct-to-mucosa was achieved according to the surgeon's preference and pancreatic texture.

Timeline

Start date
2012-06-01
Primary completion
2020-12-31
Completion
2021-02-28
First posted
2021-01-26
Last updated
2021-05-28

Source: ClinicalTrials.gov record NCT04724551. Inclusion in this directory is not an endorsement.